title: Androgen deprivation therapy and cognitive impairment?
authors.forename: Sanjeet
authors.initials: S
authors.lastname: Bagcchi
mesh_terms: D000368:Aged; D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use; D002173:Cancer Care Facilities; D016022:Case-Control Studies; D003072:Cognition Disorders / Q000139:chemically induced* / Q000453:epidemiology; D005431:Florida; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011468:Prostatectomy / Q000379:methods; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D012016:Reference Values; D018570:Risk Assessment
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal